ConCallIQ
Go Pro

Apl Apollo Tubes vs SRF Q4 FY26

Side-by-side earnings comparison across verified financials, AI summaries, management guidance, risks, quotes, and accountability signals.

Apl Apollo Tubes

neutral medium

APL Apollo reported a strong Q4 FY26 with 9% volume growth YoY and EBITDA per ton exceeding ₹5,500, driven by market leadership, product innovation, and steel shortages.

Read Apl Apollo Tubes analysis →

SRF

bullish high

SRF delivered a strong FY26 with revenue of ₹15,787 crore (+7% YoY), EBITDA of ₹3,800 crore (+29% YoY), and PAT of ₹1,835 crore (+47% YoY), driven by record fluoro-chemicals performance and margin expansion.

Read SRF analysis →

Result Snapshot

Revenue₹6,269 Cr₹4,615 Cr
PAT₹354 Cr₹582 Cr
EBITDA Margin22%
Sentimentneutralbullish

AI Summary

Apl Apollo Tubes

Q4 FY26 · Other

APL Apollo reported a strong Q4 FY26 with 9% volume growth YoY and EBITDA per ton exceeding ₹5,500, driven by market leadership, product innovation, and steel shortages. Full-year operating cash flow was ₹20 billion and free cash flow ₹13 billion, with net cash of ₹15 billion+. However, the Middle East crisis, gas shortages, and steel price volatility disrupted operations, particularly in Dubai (40% utilization) and domestic galvanized lines. Management maintains FY27 guidance of 15-20% volume growth and 20-25% PAT growth, focusing on margin protection over volume. Risks include prolonged geopolitical disruption, energy shortages, and potential demand slowdown from construction site halts.

Guidance read
Volume growth 15-20% in FY27: Management targets 15-20% volume growth for FY27, with a focus on margin protection. PAT growth 20-25% in FY27: PAT growth target of 20-25% for FY27, supported by margin expansion. EBITDA per ton sustainable at ₹5,000-5,500: Management expects EBITDA per ton to remain in the ₹5,000-5,500 range going forward. Capex of ₹14,500 crore for 8 MTPA capacity by FY28: Total capex of ₹14,500 crore over next 2.5 years to reach 8 million tonnes capacity by FY28.
Risk read
Key risks include Prolonged Middle East crisis — The ongoing war has disrupted global supply chains and impacted Dubai operations at 40% utilization.; Energy shortages in India — Gas shortages caused temporary shutdowns in March; fear of recurrence may limit production to 80-85%.; Demand slowdown from construction halts — Construction sites halted due to labor shortages and raw material price inflation, delaying purchases.; Steel price volatility and inventory risk — Rapid steel price increases may lead to destocking; however, low inventory days mitigate mark-to-market risk..
Promise ledger
Scorecard data is being built as historical quarters are processed.

SRF

Q4 FY26 · Other

SRF delivered a strong FY26 with revenue of ₹15,787 crore (+7% YoY), EBITDA of ₹3,800 crore (+29% YoY), and PAT of ₹1,835 crore (+47% YoY), driven by record fluoro-chemicals performance and margin expansion. The chemicals business grew 16% to ₹7,779 crore, while performance films and technical textiles showed recovery. Management guided for 15-20% growth in chemicals in FY27, supported by HFC debottlenecking, specialty chemicals recovery, and new capacities (HFO, fluoropolymers, BOPP). Key risks include geopolitical disruptions in the Middle East, forex mark-to-market losses, and pricing pressure in specialty chemicals from Chinese competition.

Guidance read
Chemicals business growth 15-20% in FY27: Management expects the chemicals segment to grow 15-20% in FY27, driven by HFC volumes, specialty recovery, and new capacities. HFO plant commissioning by Feb 2028: The new HFO plant in Odisha is expected to be commissioned by February 2028, with all three products coming up in parallel. BOPP line to commence production in July 2026: The new BOPP line is on track to start production in July 2026, strengthening the packaging films portfolio. PA line (BOPA) operational by September 2027: A state-of-the-art polyamide line, India's first based on simultaneous stretching, will be operational by September 2027 with an investment of ₹180 crore.
Risk read
Key risks include Geopolitical disruption in Middle East — Sales into the Middle East were impacted in Q4 due to geopolitical tensions, though management rerouted shipments to other markets.; Forex mark-to-market losses — Sharp rupee depreciation led to mark-to-market losses on forward hedges, impacting FY26 results and expected to persist near-term.; Pricing pressure from Chinese competition in specialty chemicals — Aggressive Chinese pricing has compressed margins in specialty chemicals; management expects normalization but timing uncertain.; HCFC quota uncertainty — Government has not clarified whether HCFC production will be included in baseline quota calculations, creating regulatory risk for HFC capacity expansion..
Promise ledger
Scorecard data is being built as historical quarters are processed.

Key Numbers

Apl Apollo Tubes

Q4 FY26 · Other
Quarterly Volume Growth 9%
+9% YoY

Volume increased 9% year-over-year in Q4 FY26 despite disruptions.

EBITDA per Ton ₹5,500+
+₹500+ YoY

EBITDA per ton exceeded ₹5,500, up from guided ₹5,000-5,500 range.

Net Cash Balance ₹15 billion+
+₹10 billion QoQ

Net cash increased from ₹5.5 billion in Q3 to over ₹15 billion in Q4.

Market Share 60-65%
+5-10pp YoY

Market share improved from 55% to 60-65% in FY26, aided by disruption.

SRF

Q4 FY26 · Other
HFC capacity post-debottlenecking >65,000 MTPA
+18% vs current

Debottlenecking investment of ₹88 crore to increase HFC capacity beyond 65,000 metric tons per annum.

HFO capacity investment ₹2,300 crore
New investment

New site in Odisha for 20,000 MTPA HFO capacity, backward integration, and electronic grade HF.

R&D expenditure ₹160 crore
Ongoing

Capital and revenue R&D spend in FY26; 40 patents filed, cumulative 521 filed.

Plan capex FY27 ₹2,500 crore
Consistent with growth plans

Aligned with long-term growth priorities including HFO, fluoropolymers, and pharma intermediates.

Management Guidance

Apl Apollo Tubes

Q4 FY26 · Other
G

Volume growth 15-20% in FY27

Management targets 15-20% volume growth for FY27, with a focus on margin protection.

Management guidance growth
G

PAT growth 20-25% in FY27

PAT growth target of 20-25% for FY27, supported by margin expansion.

Management guidance growth
G

EBITDA per ton sustainable at ₹5,000-5,500

Management expects EBITDA per ton to remain in the ₹5,000-5,500 range going forward.

Management guidance margins
G

Capex of ₹14,500 crore for 8 MTPA capacity by FY28

Total capex of ₹14,500 crore over next 2.5 years to reach 8 million tonnes capacity by FY28.

Management guidance capex

SRF

Q4 FY26 · Other
G

Chemicals business growth 15-20% in FY27

Management expects the chemicals segment to grow 15-20% in FY27, driven by HFC volumes, specialty recovery, and new capacities.

Management guidance revenue
G

HFO plant commissioning by Feb 2028

The new HFO plant in Odisha is expected to be commissioned by February 2028, with all three products coming up in parallel.

Management guidance expansion
G

BOPP line to commence production in July 2026

The new BOPP line is on track to start production in July 2026, strengthening the packaging films portfolio.

Management guidance expansion
G

PA line (BOPA) operational by September 2027

A state-of-the-art polyamide line, India's first based on simultaneous stretching, will be operational by September 2027 with an investment of ₹180 crore.

Management guidance expansion

Key Risks

Apl Apollo Tubes

Q4 FY26 · Other
R

Prolonged Middle East crisis

The ongoing war has disrupted global supply chains and impacted Dubai operations at 40% utilization.

high · management_commentary
R

Energy shortages in India

Gas shortages caused temporary shutdowns in March; fear of recurrence may limit production to 80-85%.

high · management_commentary
R

Demand slowdown from construction halts

Construction sites halted due to labor shortages and raw material price inflation, delaying purchases.

medium · analyst_question
R

Steel price volatility and inventory risk

Rapid steel price increases may lead to destocking; however, low inventory days mitigate mark-to-market risk.

medium · data_observation

SRF

Q4 FY26 · Other
R

Geopolitical disruption in Middle East

Sales into the Middle East were impacted in Q4 due to geopolitical tensions, though management rerouted shipments to other markets.

medium · management_commentary
R

Forex mark-to-market losses

Sharp rupee depreciation led to mark-to-market losses on forward hedges, impacting FY26 results and expected to persist near-term.

medium · management_commentary
R

Pricing pressure from Chinese competition in specialty chemicals

Aggressive Chinese pricing has compressed margins in specialty chemicals; management expects normalization but timing uncertain.

high · analyst_question
R

HCFC quota uncertainty

Government has not clarified whether HCFC production will be included in baseline quota calculations, creating regulatory risk for HFC capacity expansion.

medium · analyst_question

Key Quotes

Apl Apollo Tubes

Q4 FY26 · Other
Our focus right now is to protect our profitability and margins. When we know that volume prediction becomes challenging, because APL Apollo is the market leader, we are able to improve our margins significantly.
Sanjay Gupta · Chairman & Managing Director
If you look at our market share in FY26 versus FY25, our market share has improved to 60-65% from 55%. This can continue to improve if disruption continues to hurt our competition more than the larger player like Apollo.
Rahul Gupta · Director

SRF

Q4 FY26 · Other
We believe that the company should be able to deliver growth in the region of 15 to 20% in the coming year.
Ashish Paratra · Chairman and Managing Director
Our ability to reposition has ensured that we stayed strong in terms of the outcome for Q4.
Samir Kash · President and CFO